Fig. 1From: Controversies regarding lithium-associated weight gain: case–control study of real-world drug safety dataReporting odds ratios (RORs) and 95% confidence intervals (95%CI) of cases (N: 527) of severe weight gain (> 10% of baseline) between 2001 and 2015 for aripiprazole, carbamazepine, risperidone, lithium (LI), valproate, quetiapine, and olanzapine compared to lamotrigineBack to article page